June 2, 2010 - Elekta AB, a Swedish Medical technology company, announced June 1, it acquired oncology imaging developer Resonant Medical Inc. of Montreal, Canada, for $30 million in Canadian dollars.

Resonant Medical develops systems for image-guided radiation therapy (IGRT) of soft tissues using 3-D ultrasound technology. Founded in 2000, the company has 35 employees, most of whom are based in Montreal.

Elekta will consolidate Resonant Medical effective immediately. Resonant Medical is expected to register revenue of some CAD10 Million in fiscal 2010-2011, started 1 May 2010. The transaction will have a minor dilutive effect on reported EPS for 2010-2011 and will be slightly accretive in the next financial year.

For more information: www.elekta.com


Additional Content

News | ASTRO

Oct. 5, 2026 — The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2026 Gold Medal ...

Time October 07, 2026
arrow
News | Radiation Therapy

Oct. 1, 2026 — At ASTRO 2026 Elekta highlighted new data showing unprecedented long-term survival outcomes for patients ...

Time October 05, 2026
arrow
News | Stereotactic Body Radiation Therapy (SBRT)

Sept. 27, 2026 — Siemens Healthineers recently launched Accela, a radiotherapy solution engineered around NeoArc ...

Time October 01, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
Subscribe Now